Adaptive Trial Designs on the Rise

Date: 11 Oct. 2012  |  Topic: Adaptive Trial Design
Niklas Morton

Niklas Morton

Senior Vice President, Site and Patient Access

Adaptive trial designs are gaining increased interest both from drug developers and regulators as a means for improving clinical trial efficiencies.

Niklas Morton, vice president of global biostatistics and programming for PPD, discusses the drivers behind the growth in adaptive design, its future potential and how regulators view this burgeoning methodology.

For more information on adaptive trial design, download an executive summary of this podcast, or download a copy of our most recent white paper.

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.